Cochlear Annual Report 2008
Statements of cash flows
 Cochlear Limited and its controlled entities for the year ended 30 June 2008
Financial Report
Directors’ Report
Auditor’s Independence Declaration
Income statements
Statements of recognised income & expense
Balance sheets
Statements of cash flows
Notes to the financial statements
Directors’ Declaration
Independent Audit Report
Additional information
 
Glossary
Company Information
 

Consolidated

Company

   

2008

2007

2008

2007

 

Note

$000

$000

$000

$000

Cash flows from operating activities

         

Cash receipts from customers

 

543,493

506,589

427,996

407,018

Cash payments to suppliers and employees

 

(397,215)

(367,238)

(317,507)

(263,108)

Dividends received

 

-

-

-

1,608

Grant and other income received

 

1,871

151

1,871

151

Interest received

 

1,576

2,353

944

3,204

Interest paid

 

(11,810)

(8,892)

(3,029)

(802)

Income taxes paid

 

(53,367)

(56,127)

(33,749)

(43,397)

Net cash provided by operating activities

24(b)

84,548

76,836

76,526

104,674

Cash flows from investing activities

         

Acquisition of property, plant and equipment

 

(17,831)

(18,596)

(10,706)

(13,506)

Acquisition of enterprise resource planning system

 

(9,819)

(7,805)

(9,052)

(7,805)

Proceeds from sale of non-current assets

 

4

7,574

1

292

Investment in controlled entities

 

-

(7,953)

(26)

(30,000)

Acquisition of intangible asset

 

(1,500)

-

(1,500)

-

Acquisition of distributor businesses

 

(1,011)

-

-

-

Acquisition of manufacturing business

 

(9,286)

(9,972)

(9,286)

(9,972)

Development expenditure

 

-

(375)

-

(375)

Net cash used in investing activities

 

(39,443)

(37,127)

(30,569)

(61,366)

Cash flows from financing activities

         

Repayment of borrowings

 

(90,623)

(38,487)

(72,000)

(5,000)

Proceeds from borrowings

 

64,938

57,822

62,000

35,000

Proceeds from issue of share capital

 

12,974

3,335

12,974

3,335

Dividends paid by the parent

 

(77,852)

(60,383)

(77,852)

(60,383)

Net cash used in financing activities

 

(90,563)

(37,713)

(74,878)

(27,048)

Net (decrease)/increase
in cash and cash equivalents

 

(45,458)

1,996

(28,921)

16,260

Cash and cash equivalents,
net of overdrafts at 1 July

 

81,737

85,326

43,694

27,458

Effects of exchange fluctuation on cash held

 

408

(5,585)

31

(24)

Cash and cash equivalents,
net of overdrafts at 30 June

24(a)

36,687

81,737

14,804

43,694

The statements of cash flows are to be read in conjunction with the notes to the financial statements in this report.


Copyright © 2008 Cochlear Ltd. All Rights Reserved
Disclaimer